Movement disorders associated with the use of gabapentin

Epilepsia

Volumn 37, Issue 10, 1996, Pages 988-990

  Reeves, Andrew L ^a   So, Elson L ^a   Sharbrough, Frank W ^a   Krahn, Lois E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adverse reactions; Antiepileptic drugs; Dystonia; Gabapentin; Movement disorders

Indexed keywords

GABAPENTIN; LORAZEPAM;

ADULT; ARTICLE; CASE REPORT; CATECHOLAMINE DEPLETION; DISEASE ASSOCIATION; DYSTONIA; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EPILEPSY; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; MYOCLONUS; PRIORITY JOURNAL;

EID: 0029813903     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00537.x     Document Type: Article

References (16)

1. Lee J. Persistent dystonia associated with carbamazepine therapy: a case report. N Z Med J 1994;107:360-1.
2. Reynolds E, Trimble M. Adverse neuropsychiatric effects of anticonvulsant drugs. Drugs 1985;29:570-81.
3. Choonara IA, Rosenbloom L. Focal dystonic reaction to phenytoin [Letter]. Dev Med Child Neurol 1984;26:677-8.
4. Corey A, Koller W. Phenytoin-induced dystonia [Letter]. Ann Neurol 1983;14:92-3.
5. Hyman NM, Dennis PD, Sinclair KG. Tremor due to sodium valproate. Neurology 1979;29:1177-80.
6. Gram L, Bentsen KD. Valproate: an updated review. Acta Neurol Scand 1985;72:129-39.
7. Karas BJ, Wilder BJ, Hammond EJ, Bauman AW. Valproate tremors. Neurology 1982;32:428-32.
8. Prensky A, DeVivo D, Palkes H. Severe bradykinesia as a manifestation of toxicity to antiepileptic medications. J Pediatr 1971; 78:700-4.
9. Brennan MJ, Ruff P, Sandyk R. Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic oro-facial dystonia). Br Med J [Clin Res] 1982;285:853.
10. Godwin-Austen RB. The treatment of the choreas and athetotic dystonias. J R Coll Phys (Lond) 1979;13:35-8.
11. Chundnow RS, Lawson C, Dewey RB Jr. Choreoathetosis as a side effect of moderate-dose gabapentin therapy in severely neurologically impaired patients. Neurology 1996;46(suppl):A176.
12. Taylor C. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994;44(suppl 5):S10-6.
13. McLean M. Gabapentin. Epilepsia 1995;36(suppl 2):S73-86.
14. Welty D, Schielke G, Vartanian M, et al. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res 1993;16:175-81.
15. Schlicker E, Reimann W, Gothert M. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittelforschung/Drug Res 1985;35:1347-9.
16. McCann U, Penetar D, Belenky G. Acute dystonic reaction in normal humans caused by catecholamine depletion. Clin Neuropharmacol 1990;13:565-8.